PEG-KL4/mRNA complex (Li Ka Shing Faculty of Medicine)

N/A

Report date: 2025/01/26 16:30:10

Base Information

Drug NamePEG-KL4/mRNA complex (Li Ka Shing Faculty of Medicine)

Drug Alias NamemRNA therapeutics (Li Ka Shing Faculty of Medicine)respiratory infections mRNA vaccine (inhaled dry powder/pegylated delivery vector) (Li Ka Shing Faculty of Medicine)

ClassificationCell and gene therapy > Gene therapy > mRNASmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsLung DiseasesRespiratory Tract Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHong Kong

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Hong Kong

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Hong Kong

Inactive CompaniesN/A

Active IndicationsLung DiseasesRespiratory Tract Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A